Skip to main content

Table 1 Pattern of hRad17 staining by ovarian cancer subtype

From: Differential hRad17 expression by histologic subtype of ovarian cancer

Ovarian cancer subtype Number of cases hRad17 staining Percent
Benign 9 Nuclear 13%
Serous 72 Nuclear and cytoplasmic 42%
Endometrioid 19 Cytoplasmic 47%
Clear cell 10 Cytoplasmic 80%
Mucinous 6 Nuclear, cytoplasmic, and stromal 100%